Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -49.03%2.55M | -20.09%4.85M | 104.32%86K | 190.03%15.79M | 115.82%6.7M | 642.37%5.01M | 433.04%6.07M | -157.14%-1.99M | -68.49%5.44M | -34.62%3.1M |
| Net income from continuing operations | -61.99%558K | -105.74%-197K | -85.71%264K | 1,366.39%7.46M | 170.56%710.73K | 847.10%1.47M | 684.02%3.43M | 100.11%1.85M | -94.42%508.78K | -301.27%-1.01M |
| Operating gains losses | -219.35%-370K | 339.35%955K | 99.82%-1K | -338.19%-1.55M | -240.37%-909.21K | 169.35%310K | -189.66%-399K | -18,333.33%-547K | 146.99%648.73K | 173.97%647.73K |
| Depreciation and amortization | 14.26%1.51M | 16.72%1.51M | 33.44%1.69M | 9.51%5.05M | -19.86%1.16M | 21.23%1.33M | 21.66%1.29M | 26.50%1.27M | 11.56%4.61M | 40.03%1.45M |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --962.15K | ---- |
| Remuneration paid in stock | --0 | --0 | --0 | -83.89%36.07K | 1,346.39%2.07K | -86.36%3K | -96.77%6K | 56.25%25K | 107.89%223.83K | -100.60%-166 |
| Deferred tax | 2,480.00%516K | -99.85%1K | -85.31%47K | 277.76%1.15M | 11,010.37%154.6K | -74.03%20K | 1,073.21%657K | 84.97%320K | -84.09%304.58K | -100.29%-1.42K |
| Other non cashItems | -30.77%126K | -39.91%137K | -40.10%124K | 32.21%785.23K | -21.00%168.23K | 31.88%182K | 71.43%228K | 88.18%207K | 32.16%593.95K | 81.38%212.95K |
| Change In working capital | -15.44%838K | 1,668.47%1.96M | 54.92%-1.85M | 341.44%2.42M | 419.10%5.41M | 1,673.02%991K | 102.89%111K | -319.94%-4.09M | -121.37%-1M | -65.08%1.04M |
| -Change in receivables | 205.54%343K | 607.69%3.04M | 3.55%-3.45M | -250.92%-2.08M | -26.87%1.4M | -160.52%-325K | 135.71%429K | -11.09%-3.58M | -117.23%-591.82K | -57.82%1.91M |
| -Change in inventory | -92.72%26K | -113.91%-89K | -61.02%-1.05M | 220.67%1.38M | 149.84%1.03M | -82.58%357K | 133.99%640K | -185.73%-649K | -135.61%-1.14M | -273.78%-2.06M |
| -Change in prepaid assets | -258.82%-27K | -293.55%-240K | 33.45%-366K | 115.67%17.6K | -47.38%426.6K | -86.29%17K | 117.79%124K | -57.14%-550K | -378.43%-112.33K | 1,473.45%810.67K |
| -Change in payables and accrued expense | -47.35%496K | 31.24%-744K | 341.58%3.02M | 267.88%3.1M | 562.71%2.56M | 133.97%942K | 25.07%-1.08M | -85.39%683K | 143.77%843.06K | 113.88%386.06K |
| Tax refund paid | -188.20%-628K | -34.78%482K | 81.20%-191K | 130.77%432.54K | 98.80%-2.46K | 337.33%712K | 346.33%739K | -69.33%-1.02M | 20.13%-1.41M | 67.86%-205.67K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -49.03%2.55M | -20.09%4.85M | 104.32%86K | 190.03%15.79M | 115.82%6.7M | 642.37%5.01M | 433.04%6.07M | -157.14%-1.99M | -68.49%5.44M | -34.62%3.1M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 7.85%-763K | -43.56%-1.23M | 62.46%-452K | 71.20%-3.75M | 81.18%-864.56K | 63.12%-828K | 69.76%-854K | 64.15%-1.2M | 10.82%-13.02M | 1.45%-4.59M |
| Net PPE purchase and sale | 7.85%-763K | -43.56%-1.23M | 62.46%-452K | 71.20%-3.75M | 81.18%-864.56K | 63.12%-828K | 69.76%-854K | 64.15%-1.2M | 10.82%-13.02M | 1.45%-4.59M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 7.85%-763K | -43.56%-1.23M | 62.46%-452K | 71.20%-3.75M | 81.18%-864.56K | 63.12%-828K | 69.76%-854K | 64.15%-1.2M | 10.82%-13.02M | 1.45%-4.59M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 43.19%-663K | 87.60%-674K | -122.63%-742K | -556.68%-3.93M | -313.92%-603.08K | -311.41%-1.17M | -558.35%-5.44M | 382.67%3.28M | 123.79%859.92K | -53.99%281.92K |
| Net issuance payments of debt | 45.59%-537K | 89.69%-537K | -117.73%-618K | -379.58%-3.14M | -212.14%-433.13K | -243.04%-987K | -574.41%-5.21M | 432.00%3.49M | 134.58%1.12M | -46.34%386.23K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 299.33%297.5K | ---- |
| Interest paid (cash flow from financing activities) | 30.00%-126K | 39.65%-137K | 40.10%-124K | -39.54%-783.95K | 6.01%-169.95K | -30.43%-180K | -70.68%-227K | -88.18%-207K | -28.13%-561.82K | -69.84%-180.82K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 43.19%-663K | 87.60%-674K | -122.63%-742K | -556.68%-3.93M | -313.92%-603.08K | -311.41%-1.17M | -558.35%-5.44M | 382.67%3.28M | 123.79%859.92K | -53.99%281.92K |
| Net cash flow | ||||||||||
| Beginning cash position | 1,466.96%10.77M | 785.12%7.85M | 1,021.28%8.96M | -89.38%799.13K | 83.29%3.69M | -77.23%687K | -86.34%887K | -89.38%799K | -11.08%7.53M | -70.56%2.01M |
| Current changes in cash | -62.60%1.13M | 1,428.38%2.95M | -1,434.94%-1.11M | 220.67%8.11M | 532.74%5.23M | 396.27%3.02M | 93.58%-222K | 108.04%83K | -613.29%-6.72M | -273.15%-1.21M |
| Effect of exchange rate changes | 247.06%25K | -259.09%-35K | --0 | 673.24%52.06K | 1,464.76%42.06K | -241.67%-17K | 229.41%22K | 600.00%5K | -338.44%-9.08K | -158.77%-3.08K |
| End cash Position | 223.33%11.92M | 1,466.96%10.77M | 785.12%7.85M | 1,021.06%8.96M | 1,021.06%8.96M | 83.29%3.69M | -77.23%687K | -86.34%887K | -89.38%799.13K | -89.38%799.13K |
| Free cash from | -57.18%1.79M | -30.51%3.62M | 87.77%-391K | 258.80%12.03M | 491.36%5.83M | 366.43%4.18M | 212.23%5.21M | -2,596.88%-3.2M | -383.49%-7.58M | -1,847.62%-1.49M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.